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ABSTRACT 
N, N’-diprotonation is very easier for pyrazine Synthesis of 2, 3-diphenylquinoxaline by phenylene-diamine in 16 ml of rectified spirit was 
added & combine solution was warm in water bath for 30 min. added water until slight colorless persist & allow to cool rec rystallize the 
product in ethanol.   Synthesis of 2, 3-diphenylquinoxaline 7-sulfonylchloride (R) using chlorosulfonic acid under ice-cold condition, 
thenSynthesis of  2-hydroxyphenyl-2,3-diphenylquinoxaline-7-sulphonate (R1) throughresorcinol with 3ml pyridine &sulphonyl chloride 
derivative, Synthesis of 2-formylphenyl-2,3-diphenylquinoxaline-7-sulphonate (R7)obtained by reaction of salicylaldehyde with pyridine 
&sulphonyl chloride derivative then Synthesis of 3-formylphenyl-2,3-diphenylquinoxaline-7-sulphonate (R9) obtained by heating on water 
bath mixture of 3-hydroxybenzaldehyde with pyridine &sulphonyl chloride, Synthesized quinoxaline derivatives were subjected to antioxidant 
activity.Hydrogen peroxide solution (40 mM) was prepared with standard phosphate buffer (pH 7.4). Different concentration of the compound 
stock solution and 4ml distilled water was added to 0.6 ml of hydrogen peroxide solution. Absorbance was determined at 230 nm  after 10 min 
against a blank solution containing phosphate buffer without hydrogen peroxide. DPPH radical scavenging activity was measured using the 
method of Cotelleet al. with some modifications. 3 ml of reaction mixture containing 0.2 ml of DPPH (100 μM  in methanol) 2.8 ml of test 
solution, at various concentrations (5, 10, 20, 40, 80, 160 320 μg/ml) of the extract fractions was incubated at 37°C for 30 min absorbance of the 
resulting solution was measured at 517 nm using Beckman model DU-40 spectrophotometer. Most of the derivatives have shown comparable 
antioxidant activity in relation to standard Ascorbic acid and DPPH 
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1. INTRODUCTION: 
Pharmaceutical chemistry is the chemistry of substances 
used in medicine. It embraces the main branches of 
chemistry: radiochemistry, analytical, general, and physical 
and organic chemistry. Pharmaceutical chemistry is 
concerned more with physically and chemically oriented 
phases of drug action or availability such as 
pharmacokinetics, thermodynamics and the assay of drugs in 
drug system. Heterocyclic compounds are those cyclic 
compounds whose ring contain besides, carbon, one or more 
atoms of other elements. The non-carbon atoms such rings 
are referred to ashetero atoms. The most common hetero 
atoms are nitrogen, sulphur and oxygen. The heterocyclic 
compounds having lesser common atoms such phosphorus, 
tin, boron, silicon, bromine, etc. have been a subject of much 
investigation in recent years. The heterocyclic compounds 
having three to six carbons in the ring are numerous, but 
only those having five or six atoms in the ring are by far the 
most important. Quinoxalines are becoming the attractive 
target of extensive research due to its inherent diverse 
properties. Various potential activities of the quinoxalines 
have been explored recently like, antimicrobial agents, 
cytotoxic agents, anti-tubercular, anxiolytic, anti-HIV, anti-
inflammatory, antioxidant etc. In the recent year, 2, 3 
Disubstitutedquinoxalines reported to posse’s significant 
antimicrobial potential against bacteria, fungi, and 
mycobacterium (Ganapaty S. et al 2007). Designs of 
quinoxaline antibiotics have undertaken by several workers, 
but they possess limited application due to their toxic effect. 
According to conclusion derived in literature survey, it was 
worthwhile to introduced lipophillic moiety into the 2,3 
diphenylquinoxaline system to make the structure as DNA 
targeted potent antimicrobial agent the sulfonate have 
created considerable attention as carrier and lipophillic core 
in the area of synthetic medicinal chemistry. Based on the 
observation and in connection with earlier studies 
(Ganapatyetal, 2007), the present work was undertaken 
synthesize some new phenol &aldehyde derivatives of 2, 3 
diphenylquinoxaline 7 sulphonyl chloride which are more 
potential as antibacterial than parent quinoxalines. 
Goyal et al                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):1240-1244 
ISSN: 2250-1177                                                                                  [1241]                                                                                 CODEN (USA): JDDTAO 
2. MATERIALS AND METHODS: 
Synthetic Scheme 1: 
NH2
NH2
+ O
O
Ethanol
Heat for 30 min.
N
N
ClSO3H
N
N S
O
O
Cl
benzene-1,2-diamine 1,2-diphenylethane-1,2-dione
2,3-diphenylquinoxaline
2,3-diphenylquinoxaline-7-Sulphonyl Chloride  
2.1 Synthetic Scheme 2: 
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2.2 Synthetic Scheme 3: 
 
 
2.3 Experimental Procedure: 
2.3.1 Synthesis of 2, 3-diphenylquinoxaline 
To warm solution of 4.2 gram of benzyl in 16 ml of rectified 
spirit, the solution of 2.2ml of o-phelynediamine in 16 ml of 
rectified spirit was added & combine solution was warm in 
water wath for 30 min. added water until slight colourless 
persist & allow to cool. Filter & recrystallize the product in 
ethanol.      
2.3.2 Synthesis of 2-hydroxyphenyl-2,3-diphenylquinoxaline-
7-sulphonate(R1) 
Mix 1.17gm of  resorcinol with 3ml pyridine & 2.34 gm of 
sulphonyl chloride derivative &heat on water bath for 1 hr. 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dilHCl to remove pyridine and cold 
dilNaOH  to remove any phenol present &them with cold 
water , recrystallized from methanol or ethanol. 
2.3.3Synthesis of Phenyl-2,3-diphenylquinoxaline-7-
sulphonate (R2) 
Mix 1 gm of  phenol with 2.5ml pyridine & 2 gm of sulphonyl 
chloride derivative & heat on water bath for 1 hr. pour into 
25 ml of cold water & stir until the oil solidifies , filter wash 
with cold dilHCl to remove pyridine and cold dilNaOH  to 
remove any phenol present &them with cold water , 
recrystallized from methanol or ethanol. 
2.3.4 Synthesis of 4-hydroxyphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R3) 
Mix 1.17 gm of  quinol with 3ml pyridine & 2.34 gm of 
sulphonyl chloride derivative &heat on water bath for 55min 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dilHCl to remove pyridine and cold 
dilNaOH  to remove any phenol present & them with cold 
water , recrystallized from methanol or ethanol. 
4.3.2.4 Synthesis of 4-Chlorophenyl-2,3-
diphenylquinoxaline-7-sulphonate(R4) 
Mix 1.36 gm of 4-chloro  phenol with 3.4ml pyridine & 2.72 
gm of sulphonyl chloride derivative &heat on water bath for 
1 hr. pour into 25 ml of cold water & stir until the oil 
solidifies , filter wash with cold dilHCl to remove pyridine 
and cold dilNaOH  to remove any phenol present &them with 
cold water , recrystallized from methanol or ethanol. 
2.3.5 Synthesis of Napthalene-1-yl-2,3-
diphenylquinoxaline-7-sulphonate(R5) 
Mix 1.54gm of  1-naphthol with 3.85ml pyridine & 3.08 gm 
of sulphonyl chloride derivative &heat on water bath for 2 
hr. pour into 25 ml of cold water & stir until the oil solidifies 
, filter wash with cold dilHCl to remove pyridine and cold 
dilNaOH  to remove any phenol present &them with cold 
water , recrystallized from methanol or ethanol. 
2.3.6 Synthesis of Napthalene-2-yl-2,3-
diphenylquinoxaline-7-sulphonate (R6) 
Mix 1.54 gmof  2-naphthol with 3.85ml pyridine & 3.08 gm 
of sulphonyl chloride derivative &heat on water bath for 
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2.15 hr. pour into 25 ml of cold water & stir until the oil 
solidifies , filter wash with cold dilHCl to remove pyridine 
and cold dilNaOH  to remove any phenol present &them with 
cold water , recrystallized from methanol or ethanol. 
2.3.7 Synthesis of 2-formylphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R7)  
Mix 1.29 gm of  salicylaldehyde with 3.22ml pyridine & 2.58 
gm of sulphonyl chloride derivative &heat on water bath for 
1.5 hr. pour into 25 ml of cold water & stir until the oil 
solidifies , filter wash with cold dilHCl to remove pyridine 
and cold dilNaOH  to remove any phenol present &them with 
cold water , recrystallized from methanol or ethanol. 
2.3.8Synthesis of 4-formyl-3-methoxyphenyl-2,3-
diphenylquinoxaline-7-sulphonate (R8) 
Mix 1.61 gm of  vanillin with4.02 ml pyridine & 3.22 gm of 
sulphonyl chloride derivative & heat on water bath for 3 hr. 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dilHCl to remove pyridine and cold 
dilNaOH  to remove any phenol present &them with cold 
water , recrystallized from methanol or ethanol. 
2.3.9Synthesis of 3-formylphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R9) 
Mix 1.29 gm of 3-hydroxybenzaldehyde with 3.22ml 
pyridine & 2.58 gm of sulphonyl chloride derivative &heat 
on water bath for 2.15 hr. pour into 25 ml of cold water & 
stir until the oil solidifies , filter wash with cold dilHCl to 
remove pyridine and cold dilNaOH  to remove any phenol 
present &them with cold water , recrystallized from 
methanol or ethanol. 
2.3.10 Synthesis of S-2-formylphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R10) 
 Mix 1.46 gm of 2-mercapto benzaldehyde with 3.67ml 
pyridine & 2.92 gm of sulphonyl chloride derivative &heat 
on water bath for 2 hr. pour into 25 ml of cold water & stir 
until the oil solidifies, filter wash with cold dilHCl to remove 
pyridine and cold dilNaOH  to remove any phenol present 
&them with cold water, recrystallized from methanol or 
ethanol. 
3. PHARMACOLOGICAL ACTIVITY: 
3.2 Antioxidant Screening 
3.2.1 Hydrogen Peroxide Scavenging Assays 
Hydrogen peroxide solution (40 mM) was prepared with 
standard phosphate buffer (pH 7.4). Different concentration 
of the compound stock solution and 4ml distilled water was 
added to 0.6 ml of hydrogen peroxide solution. Absorbance 
was determined at 230 nm after 10 min against a blank 
solution containing phosphate buffer without hydrogen 
peroxide. The percentage scavenging activity at different 
concentrations of the different derivatives compared with 
the standard, ascorbic acid.  
% Inhibition = (Ac – At/Ac) X 100 
Where, Ac – Absorbance of control and At – Absorbance of 
test 
3.2.21,1-Diphenyl-2, Picryl Hydrazyl Method (DPPH) 
DPPH radical scavenging activity was measured using the 
method of Cotelleet al. with some modifications. 3 ml of 
reaction mixture containing 0.2 ml of DPPH (100 μM in 
methanol) 2.8 ml of test solution, at various concentrations 
(5, 10, 20, 40, 80, 160 320 μg/ml) of the extract fractions 
was incubated at 37°C for 30 min absorbance of the 
resulting solution was measured at 517 nm using Beckman 
model DU-40 spectrophotometer. The percentage inhibition 
of DPPH radical was calculated by comparing the results of 
the test with those of the control (not treated with extract) 
using the following equation: (Navkar S. et al, 2010).  
% inhibition=(1–absorbance of test/absorbance of control)×100 
4. RESULT AND DISCUSSION: 
4.1Antioxidant Screening 
4.1.1 Hydrogen peroxide scavenging activity 
Table 1: Hydrogen peroxide scavenging assay 
Concentration 50  µg/ml 100 µg/ml 200 µg/ml 
R1 45.2 65.30 72.27 
R3 36.8 56.93 85.27 
R4 18.4 18.53 28.00 
R7 34.5 49.80 87.28 
R10 30.45 40.52 84.24 
Ascorbic acid 49.4 71.32 89.96 
 
 
 
Figure 1: Hydrogen peroxide scavenging assay 
 
4.1.2: 1, 1 diphenyl 2, picryl hydrazyl Method (DPPH) 
Table 2:1, 1 diphenyl 2, picryl hydrazyl Method (DPPH) 
Concentration 100mcg/ml 200mcg/ml 400mcg/ml 
R1 71.16 83.03 91.92 
R3 71.04 83.48 89.26 
R4 76.89 88.57 97.54 
R7 85.71 86.21 88.00 
R10 74.81 87.93 95.96 
 
CONCLUSION: 
The newly synthesized phenol and aldehydes derivatives 
were screened for antioxidant activity. The results of 
pharmacological screenings are satisfactory. Most of the 
derivatives have shown comparable antioxidant activity in 
relation to standard Ascorbic acid and DPPH at 100, 200 and 
400mcg/ml were found 85.71,86.21 and 88.00 for R7 
respectively. 
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